It promotes proliferation of GBM cells by targeting both MXI1, a c-Myc inhibitor (Zhou et al., 2013) and targets a p38 isoform which promotes apoptosis (Liu et al., 2015). The gene discussed is MYC; the disease is glioblastoma.